DE69611360D1 - Succinamid-derivate und ihre verwendung als metallproteinase-inhibitoren - Google Patents

Succinamid-derivate und ihre verwendung als metallproteinase-inhibitoren

Info

Publication number
DE69611360D1
DE69611360D1 DE69611360T DE69611360T DE69611360D1 DE 69611360 D1 DE69611360 D1 DE 69611360D1 DE 69611360 T DE69611360 T DE 69611360T DE 69611360 T DE69611360 T DE 69611360T DE 69611360 D1 DE69611360 D1 DE 69611360D1
Authority
DE
Germany
Prior art keywords
pct
date oct
sec
proteinase inhibitors
metal proteinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69611360T
Other languages
English (en)
Other versions
DE69611360T2 (de
Inventor
Paul Beckett
Andrew Miller
Marie Spavold
Mark Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE69611360D1 publication Critical patent/DE69611360D1/de
Publication of DE69611360T2 publication Critical patent/DE69611360T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Lubricants (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69611360T 1995-04-18 1996-04-18 Succinamid-derivate und ihre verwendung als metallproteinase-inhibitoren Expired - Fee Related DE69611360T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9507799.6A GB9507799D0 (en) 1995-04-18 1995-04-18 Metalloproteinase inhibitors
PCT/GB1996/000930 WO1996033161A1 (en) 1995-04-18 1996-04-18 Derivatives of succinamide and their use as metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
DE69611360D1 true DE69611360D1 (de) 2001-02-01
DE69611360T2 DE69611360T2 (de) 2001-06-13

Family

ID=10773096

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69611360T Expired - Fee Related DE69611360T2 (de) 1995-04-18 1996-04-18 Succinamid-derivate und ihre verwendung als metallproteinase-inhibitoren
DE69609957T Expired - Fee Related DE69609957T2 (de) 1995-04-18 1996-04-18 Succinamid-derivate und ihre verwendung als metalloproteinaseinhibitoren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69609957T Expired - Fee Related DE69609957T2 (de) 1995-04-18 1996-04-18 Succinamid-derivate und ihre verwendung als metalloproteinaseinhibitoren

Country Status (9)

Country Link
US (2) US5840939A (de)
EP (2) EP0821666B1 (de)
JP (2) JPH11503748A (de)
AT (2) ATE198319T1 (de)
AU (1) AU5343696A (de)
DE (2) DE69611360T2 (de)
ES (2) ES2150116T3 (de)
GB (1) GB9507799D0 (de)
WO (2) WO1996033165A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU1812197A (en) * 1996-03-01 1997-09-16 Sankyo Company Limited Hydroxamic acid derivatives
US5840974A (en) * 1996-12-04 1998-11-24 Britisch Biotech Pharmaceuticals, Ltd. Metalloproteinase inhibitors
US5952320A (en) * 1997-01-07 1999-09-14 Abbott Laboratories Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
US5985911A (en) * 1997-01-07 1999-11-16 Abbott Laboratories C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
ZA9818B (en) * 1997-01-07 1998-07-02 Abbott Lab C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion
NZ504683A (en) * 1998-01-09 2002-06-28 Pfizer Amide derivatives and pharmaceutical compositions thereof and their use as matrix metalloprotease inhibitors
GB9810464D0 (en) 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds
HRP990246A2 (en) * 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
NZ525513A (en) 1998-08-07 2004-09-24 Pont Pharmaceuticals Du Succinoylamino lactams as inhibitors of Abeta protein production
US6288261B1 (en) 1998-12-18 2001-09-11 Abbott Laboratories Inhibitors of matrix metalloproteinases
EP1313426A2 (de) 1998-12-24 2003-05-28 Bristol-Myers Squibb Pharma Company Succinoylaminobenzodiazepine als inhibitoren der a-beta proteinproduktion
US6297337B1 (en) 1999-05-19 2001-10-02 Pmd Holdings Corp. Bioadhesive polymer compositions
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
US6503902B2 (en) 1999-09-13 2003-01-07 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
WO2001027108A1 (en) 1999-10-08 2001-04-19 Bristol-Myers Squibb Pharma Company AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
US6525044B2 (en) 2000-02-17 2003-02-25 Bristol-Myers Squibb Company Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production
US6803383B2 (en) * 2000-03-27 2004-10-12 The Scripps Research Institute Inhibition of angiogenesis and tumor growth
US6495540B2 (en) 2000-03-28 2002-12-17 Bristol - Myers Squibb Pharma Company Lactams as inhibitors of A-β protein production
CN1436175A (zh) 2000-04-03 2003-08-13 布里斯托尔-迈尔斯斯奎布药品公司 作为Aβ－蛋白生产抑制剂的环状内酰胺
JP2004508289A (ja) 2000-04-03 2004-03-18 デュポン　ファーマシューティカルズ　カンパニー Ａβタンパク質産生の阻害剤としての環状ラクタム
CA2404273A1 (en) 2000-04-11 2001-10-18 Bristol-Myers Squibb Pharma Company Substituted lactams as inhibitors of a.beta. protein production
AR028606A1 (es) * 2000-05-24 2003-05-14 Smithkline Beecham Corp Nuevos inhibidores de mmp-2/mmp-9
EP1268450A1 (de) 2000-06-01 2003-01-02 Bristol-Myers Squibb Pharma Company Durch bernsteinsäurediamid substituierte lactamverbindungen als a-beta-protein-produktionsinhibitoren
AU2002230385A1 (en) * 2000-09-25 2002-04-15 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
US20050112261A1 (en) * 2003-11-21 2005-05-26 Davis Robert J. Churros and method for making same
KR101155335B1 (ko) * 2005-01-07 2012-06-11 엘지전자 주식회사 이동통신 단말기의 멀티미디어 메시지 동작방법
BRPI0715677A2 (pt) * 2006-08-21 2013-07-09 Hoffmann La Roche amidas substituÍdas di-aromÁticas como inibidores para glyt1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058797A1 (en) * 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
AU666727B2 (en) * 1992-06-25 1996-02-22 F. Hoffmann-La Roche Ag Hydroxamic acid derivatives
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
GB2290543B (en) * 1993-03-16 1996-05-22 British Biotech Pharm Hydroxamic acid derivatives as metalloproteinase inhibitors
AU7270794A (en) * 1993-08-02 1995-02-28 Celltech Limited Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
DE69502378T2 (de) * 1994-01-20 1998-10-01 British Biotech Pharm Metalloproteinaseinhibitoren

Also Published As

Publication number Publication date
WO1996033161A1 (en) 1996-10-24
US5908851A (en) 1999-06-01
DE69611360T2 (de) 2001-06-13
ATE195723T1 (de) 2000-09-15
WO1996033165A1 (en) 1996-10-24
ES2150116T3 (es) 2000-11-16
DE69609957D1 (de) 2000-09-28
ES2153959T3 (es) 2001-03-16
EP0821666B1 (de) 2000-12-27
EP0821668B1 (de) 2000-08-23
EP0821668A1 (de) 1998-02-04
GB9507799D0 (en) 1995-05-31
ATE198319T1 (de) 2001-01-15
EP0821666A1 (de) 1998-02-04
JPH11503746A (ja) 1999-03-30
JPH11503748A (ja) 1999-03-30
DE69609957T2 (de) 2001-03-01
AU5343696A (en) 1996-11-07
US5840939A (en) 1998-11-24

Similar Documents

Publication Publication Date Title
DE69611360D1 (de) Succinamid-derivate und ihre verwendung als metallproteinase-inhibitoren
ATE164837T1 (de) Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung
ATE204857T1 (de) Meta-substituierte phenylenderivate und ihre verwendung als alphavbeta3 intergrin-antagonisten oder inhibitoren
DE69928697D1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
PT100606A (pt) Derivados fluoroalcoxibenzilamino de heterociclos contendo azoto
PT1045690E (pt) Benzenossulfonamidas inibidoras da pde-iv e seu uso terapeutico
AU1070895A (en) Indole-derived arylpiperazines as ligands for 5HT1-like receptors 5HT1B and 5HT1D
ATE155133T1 (de) Piperazinderivate als 5-ht antagonisten
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
NO944892L (no) N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv.
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
ATE145206T1 (de) Oxindol 1-(n-(alkoxycarbonyl)>carboxamide und 1- (n-carboxamido>carboxamide als antiinflammatorische wirkstoffe
DE69405760D1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
ATE176225T1 (de) Heterocyclische benzolsulfonyliminderivate als inhibitoren der il-1 wirkung
SE9402241L (sv) Inhibitor
DE69711221D1 (de) Metalloproteinase-inhibitoren
ATE177098T1 (de) Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
EP1325918A4 (de) Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
ATE196134T1 (de) Substituierte chinolinderivate, und ihre verwendung als inhibitoren der magensekretion
NO954316D0 (no) Benzo(f)kinoksalidinonderivater, deres fremstilling og anvendelse i legemidler
DE59310218D1 (de) Inhibitoren retroviraler proteasen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee